Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Kunst

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 26, 2024
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under UncertaintyReza Yaesoubi, Natalia Kunst
JAMA Internal Medicine|August 11, 2020
Breast Cancer Screening and Health Care Costs-ReplyNatalia Kunst, Cary P Gross
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 22, 2025
Long-Term Outcomes and Cost-Effectiveness of Artificial Intelligence for Breast Cancer Screening: A Modeling StudyMatthew Andersen, Natalia Kunst, Ilana B Richman
Applied Health Economics and Health Policy|May 28, 2021
A Review of Web-Based Tools for Value-of-Information AnalysisHaitham Tuffaha, Claire Rothery, Natalia Kunst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Cost-Effectiveness Analysis of <sup>177</sup>Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care PerspectiveKemal C Gogebakan, Natalia Kunst, Alireza Ghodsi, et al.
American Journal of Hematology|February 11, 2022
Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopeniaGeorge Goshua, Pranay Sinha, Natalia Kunst, et al.
Pharmacoeconomics|February 11, 2025
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal HaemoglobinuriaJeremiah Donoghue, Matthew Youngs, Alex Reeve, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 19, 2022
Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness ComparisonHenri B Wolff, Venetia Qendri, Natalia Kunst, et al.
Gynecologic Oncology|November 13, 2022
The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trialTara Knauss, Bo T Hansen, Kine Pedersen, et al.
Pharmacoeconomics|December 29, 2023
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making FrameworkNatalia Kunst, Emily A Burger, Veerle M H Coupé, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 26, 2024
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under UncertaintyReza Yaesoubi, Natalia Kunst
JAMA Internal Medicine|August 11, 2020
Breast Cancer Screening and Health Care Costs-ReplyNatalia Kunst, Cary P Gross
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 22, 2025
Long-Term Outcomes and Cost-Effectiveness of Artificial Intelligence for Breast Cancer Screening: A Modeling StudyMatthew Andersen, Natalia Kunst, Ilana B Richman
Applied Health Economics and Health Policy|May 28, 2021
A Review of Web-Based Tools for Value-of-Information AnalysisHaitham Tuffaha, Claire Rothery, Natalia Kunst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Cost-Effectiveness Analysis of <sup>177</sup>Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care PerspectiveKemal C Gogebakan, Natalia Kunst, Alireza Ghodsi, et al.
American Journal of Hematology|February 11, 2022
Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopeniaGeorge Goshua, Pranay Sinha, Natalia Kunst, et al.
Pharmacoeconomics|February 11, 2025
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal HaemoglobinuriaJeremiah Donoghue, Matthew Youngs, Alex Reeve, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 19, 2022
Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness ComparisonHenri B Wolff, Venetia Qendri, Natalia Kunst, et al.
Gynecologic Oncology|November 13, 2022
The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trialTara Knauss, Bo T Hansen, Kine Pedersen, et al.
Pharmacoeconomics|December 29, 2023
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making FrameworkNatalia Kunst, Emily A Burger, Veerle M H Coupé, et al.
Pageof 5